New York State Common Retirement Fund
GBIO

New York State Common Retirement Fund’s Generation Bio GBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-268
Closed -$1.09K – 3246
2025
Q1 		$1.09K Hold
268
– – ﹤0.01% 3165
2024
Q4 		$2.84K Hold
268
– – ﹤0.01% 3157
2024
Q3 		$6.63K Hold
268
– – ﹤0.01% 3133
2024
Q2 		$7.56K Buy
268
+2
+0.8% +$65 ﹤0.01% 3242
2024
Q1 		$10.8K Hold
266
– – ﹤0.01% 3188
2023
Q4 		$4.39K Sell
266
-11
-4% -$192 ﹤0.01% 3224
2023
Q3 		$10.5K Buy
277
+11
+4% +$521 ﹤0.01% 3214
2023
Q2 		$14.6K Sell
266
-4
-1% -$184 ﹤0.01% 3250
2023
Q1 		$11.6K Sell
270
-2,334
-90% -$113K ﹤0.01% 3169
2022
Q4 		$102K Buy
2,604
+1
+0% +$53 ﹤0.01% 2950
2022
Q3 		$138K Buy
2,603
+11
+0.4% +$688 ﹤0.01% 2907
2022
Q2 		$170K Buy
2,592
+865
+50% +$56.5K ﹤0.01% 2869
2022
Q1 		$127K Sell
1,727
-1,420
-45% -$82.3K ﹤0.01% 2968
2021
Q4 		$223K Sell
3,147
-14
-0.4% -$2.44K ﹤0.01% 2831
2021
Q3 		$792K Sell
3,161
-762
-19% -$182K ﹤0.01% 2223
2021
Q2 		$1.05M Buy
3,923
+1,703
+77% +$509K ﹤0.01% 2208
2021
Q1 		$632K Buy
2,220
+1,100
+98% +$352K ﹤0.01% 2339
2020
Q4 		$318K Buy
1,120
+560
+100% +$180K ﹤0.01% 2565
2020
Q3 		$173K Buy
+560
New +$134K ﹤0.01% 2707

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York State Common Retirement Fund's GBIO Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 268 shares — an estimated $1.09K sold.

New York State Common Retirement Fund first reported a position in GBIO in Q3 2020 and held it in 19 quarters. The position peaked at $1.05M in Q2 2021. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 268 Generation Bio shares in Q2 2025, an estimated $1.09K.
  • New York State Common Retirement Fund first reported a position in Generation Bio in Q3 2020 and held it in 19 quarters.
  • New York State Common Retirement Fund's Generation Bio position peaked at $1.05M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.